Journal of Convergence Korean Medicine (대한융합한의학회지)

Academy of Convergence Korean Medicine (대한융합한의학회)
권호 표지

Protective effects of Terminalia chebula Retzins (TC) water extract on acute pancreatitis

가자(訶子)의 급성 췌장염 보호 효과

  • Bitna Kweon (Department of Pharmacology, School of Korean Medicine, Wonkwang University) ;
  • Dong-Uk Kim (Department of Pharmacology, School of Korean Medicine, Wonkwang University) ;
  • Gi-Sang Bae (Department of Pharmacology, School of Korean Medicine, Wonkwang University)
  • 권빛나 (원광대학교 한의과대학 약리학교실) ;
  • 김동욱 (원광대학교 한의과대학 약리학교실) ;
  • 배기상 (원광대학교 한의과대학 약리학교실)
  • Published : 2023.12.31
Download PDF
⟨ Previous Next ⟩

Abstract

Objectives: Terminalia chebula Retzins (TC) has been used as a traditional remedy to treat gastrointestinal infectious and inflammatory diseases. However, the protective effect of TC on acute pancreatitis (AP) has not been studied. In this study, we tried to investigate the protective effect of TC water extract on cerulein-induced AP. Methods: To measure the protective effect of TC on AP, mice were injected with cerulein (50 ㎍/kg) hourly for 6 times. TC water extract (200 or 400 mg/kg) or saline was administered orally 1 h before the first injection of cerulein. The mice were sacrificed at 6 h after the last injection of cerulein. Pancreas tissues were taken for further analysis. Results: The administration of TC water extract showed an inhibitory effect on the increase of pancreas weight/body weight ratio and mitigated pancreatic damage in mice. Also, mRNA level of pro-inflammatory cytokines was inhibited by administration of TC water extract. Conclusion: Taken together, we found that administration of TC water extract ameliorates the severity of cerulein-induced AP, which suggests the potential to be an effective treatment on AP.

Keywords

Acknowledgement

이 논문은 정부(교육부)의 재원으로 한국연구재단의 지원을 받아 수행된 연구임(NRF-2021R1I1A2053285).

References

  1. Collaborators GBDC. The global, regional, and national burden of cirrhosis by cause in 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet Gastroenterol Hepatol. 2020;5(3):245-66.
  2. Petrov MS, Shanbhag S, Chakraborty M, Phillips AR, Windsor JA. Organ failure and infection of pancreatic necrosis as determinants of mortality in patients with acute pancreatitis. Gastroenterology. 2010;139(3):813-20. https://doi.org/10.1053/j.gastro.2010.06.010
  3. Bhatia M, Neoptolemos JP, Slavin J. Inflammatory mediators as therapeutic targets in acute pancreatitis. Curr Opin Investig Drugs. 2001 ; 2(4) : 496-501.
  4. Kimura W, Mossner J. Role of hypertriglyceridemia in the pathogenesis of experimental acute pancreatitis in rats. Int J Pancreatol. 1996 ; 20(3) : 177-84. https://doi.org/10.1007/BF02803766
  5. Jenkins DJ, Kendall CW, Augustin LS, Franceschi S, Hamidi M, Marchie A, Jenkins AL, Axelsen M. Glycemic index : Overview of implications in health and disease. Am J clin Nutr. 2002 ; 76(1) : 266S-73S. https://doi.org/10.1093/ajcn/76.1.266S
  6. Kim IR KH, Kuk YB, Park SJ, Park YK, Park JH, Seo BI, Seo YB, Shin MK, Lee YJ, LeeYC, Lee JH, Leem KH, Cho SI, Chung JK, Joo YS, Choi HY. Boncho-Hak. Seoul : Young-Lim Press. 2007 : 671-2.
  7. Lee KS, Kim SH, Sim KC, Park CS, Shin YS. Antimicrobial activity of Terminalia chebula Retz. extract of against intestinal pathogens. Korean J Food & Nutr 1997;10: 559-563.
  8. Bag A, Kumar Bhattacharyya S, Kumar Pal N, Ranjan Chattopadhyay R. Anti-inflammatory, anti-lipid peroxidative, antioxidant and membrane stabilizing activities of hydroalcoholic extract of Terminalia chebula fruits. Pharm Biol. 2013;51(12):1515-1520. https://doi.org/10.3109/13880209.2013.799709
  9. Achari C, Reddy GV, Reddy TC, Reddanna P. Chebulagic acid synergizes the cytotoxicity of doxorubicin in human hepatocellular carcinoma through COX-2 dependant modulation of MDR-1. Med Chem. 2011;7:432-442. https://doi.org/10.2174/157340611796799087
  10. Weiss FU, Laemmerhirt F, Lerch MM. Etiology and Risk Factors of Acute and Chronic Pancreatitis. Visc Med. 2019;35(2):73-81. https://doi.org/10.1159/000499138
  11. Bhatia M, Wong FL, Cao Y, Lau HY, Huang J, Puneet P,Chevali L. Pathophysiology of acute pancreatitis. Pancreatology. 2005 ; 5 : 132-144. https://doi.org/10.1159/000085265
  12. Regner S, Manjer J, Appelros S, Hjalmarsson C, Sadic J, Borgstrom A. Protease activation, pancreatic leakage, and inflammation in acute pancreatitis: differences between mild and severe cases and changes over the first three days. Pancreatology. 2008 ; 8 : 600-607. https://doi.org/10.1159/000161011
  13. Kim SC, Yang HR. Clinical efficacy of gabexate mesilate for acute pancreatitis in children. Eur J Pediatr. 2013 ; 172(11) : 1483-90.
  14. Kesharwani A, Polachira SK, Nair R, Agarwal A, Mishra NN, Gupta SK. Anti-HSV-2 activity of Terminalia chebula Retz extract and its constituents, chebulagic and chebulinic acids. BMC Complement Altern Med. 2017;17(1):110.
  15. Patil VS, Harish DR, Vetrivel U, Roy S, Deshpande SH, Hegde HV. Hepatitis C Virus NS3/4A Inhibition and Host Immunomodulation by Tannins from Terminalia chebula: A Structural Perspective. Molecules. 2022;27(3):1076 https://doi.org/10.3390/molecules27031076
  16. Saleem A, Husheem M, Harkonen P, Pihlaja K. Inhbition of cancer cell growth by crude extract and the phenolics of Terminalia chebula Retz. fruit. J Ethnopharmacol. 2002;81:327-336. https://doi.org/10.1016/S0378-8741(02)00099-5
  17. Sabu MC, Kuttan R. Anti-diabetic activity of medicinal plants and its relationship with their antioxidant property. J Ethnopharmacol. 2002;81:155-160. https://doi.org/10.1016/S0378-8741(02)00034-X
  18. Malekzadeh F, Ehsanifar H, Shahamat M, Levin M, Colwell RR. Antibacterial activity of black myrobalan (Terminalia chebula Retz) against Helicobacter pylori. Int J Antimicrob Ag. 2001;18:85-88. https://doi.org/10.1016/S0924-8579(01)00352-1
  19. Jagtap AG, Karkera SG. Potential aqueous extract of Terminalia Chebula as an anticaries agent. J Ethnopharmocol. 1999;68:299-306. https://doi.org/10.1016/S0378-8741(99)00058-6
  20. Bae Gs, Kim MS, Park KC, Koo BS, Jo IJ, Choi SB, Lee DS, Kim YC, Kim TH, Seo SW, Shin YK, Song HJ, Park SJ. Effect of biologically active fraction of Nardostachys jatamansi on cerulein-induced acute pancreatitis. World J Gastroenterol. 2012 ; 18(25) : 3223-34.
  21. Lee HS. Experimental animal models of pancreatic disease. Kor J Gastroenterol seminar. 2002 : 144-51.
  22. Granger J, Remick D. Acute pancreatitis : models, markers, nad mediators. Shock. 2005 ; 24(1) : 45-51. https://doi.org/10.1097/01.shk.0000191413.94461.b0
  23. Osman MO, Jensen SL. Acute pancreatitis: the pathophysiological role of cytokines and integrins. New trends for treatment? Dig Surg. 1999;16(5):347-62. https://doi.org/10.1159/000018746
  24. Rao SA, Kunte AR. Interleukin-6: An Early Predictive Marker for Severity of Acute Pancreatitis. Indian J Crit Care Med. 2017;21(7):424-8. https://doi.org/10.4103/ijccm.IJCCM_478_16